Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Andrew Forson: Strong performance at the stablecoin level

Andrew Forson: Strong performance at the stablecoin level

AiCoinAiCoin2026/05/28 16:37
Show original
DeFi Technologies President Andrew Forson stated that stablecoins are performing strongly, with stablecoins like USDT and USDC backed by over $150 billion in US Treasury bonds, and trading volumes growing 20% to 30% each month. Despite a $2 billion decrease in total value locked and several high-profile hacking incidents, he believes that the transparency and 24/7 continuous operation of open blockchains make DeFi more resilient than traditional finance. Meanwhile, Wall Street giants such as BlackRock, JPMorgan, and Morgan Stanley are accelerating their entry into tokenization and crypto services.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD

Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.

智通财经2026/09/21 07:16

Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.

U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).

智通财经2026/09/21 07:11

Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential

According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.

智通财经2026/09/21 07:11

Autoimmune and inflammatory disease pharmaceutical company TRex Bio (TRX.US) applies for US listing, plans to raise up to 100 millions dollars.

TRex Bio filed documents with the U.S. Securities and Exchange Commission (SEC) last Friday, intending to raise up to 100 million USD through an initial public offering (IPO).

智通财经2026/09/21 07:11